|
Home : Unsafe Drugs : Avandia : News Articles : Medical News: 2010 in Review: Reform, SGR, Diet Drugs, Stem Cells - in Washington-Watch, Washington Watch from MedPage Today Medical News: 2010 in Review: Reform, SGR, Diet Drugs, Stem Cells - in Washington-Watch, Washington Watch from MedPage Today
After years of controversy over the diabetes drug rosiglitazone (Avandia), the FDA decided in September that it can remain on the market -- but new patients can receive it only if their blood sugar can't be controlled with pioglitazone (Actos) or other medications. However, in ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




